Literature DB >> 70489

Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism.

J E Swierkosz, R H Swanborg.   

Abstract

We determined requirements for the induction of immunoregulatory suppressor cells in experimental allergic encephalomyelitis (EAE) in Lewis rats. Pretreatment of rats with myelin basic protein (BP) in incomplete Freund's adjuvant (IFA) stimulates the proliferation of suppressor cells that localize in lymph nodes and spleen (but not thymus) and exert control over the development of clinical EAE. Dosage studies revealed that 3 X 10(7) suppressor cells can adoptively transfer suppression to syngeneic recipients. Transferred unresponsiveness wanes within 3 weeks, indicating that the suppressor cells are short-lived lymphocytes, although actively induced unresponsiveness persists for at least 8 weeks, probably as a result of continual proliferation under the influence of antigen. No evidence was obtained to suggest that antigen carry-over or blocking antibody production accounts for adoptive transfer of unresponsiveness. Suppressor cells apparently act at the inductive phase of the immune response since they had no inhibitory effect on adoptive transfer of disease by effector lymph node cells. Other mechanisms also may play a role in unresponsiveness to EAE, since rats pretreated i.v. with high dosages of soluble BP were temporarily rendered unresponsive, although suppressor cells could not be detected in these animals.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70489

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Immunoregulation in Heymann nephritis. II. Functional studies.

Authors:  J Cornish; A Z Barabas; R Lannigan; J Rozing
Journal:  Br J Exp Pathol       Date:  1989-10

2.  Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.

Authors:  Harald H Hofstetter; Andra Kovalovsky; Carey L Shive; Paul V Lehmann; Thomas G Forsthuber
Journal:  J Neuroimmunol       Date:  2007-05-04       Impact factor: 3.478

3.  IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells.

Authors:  Thomas Korn; Meike Mitsdoerffer; Andrew L Croxford; Amit Awasthi; Valérie A Dardalhon; George Galileos; Patrick Vollmar; Gretta L Stritesky; Mark H Kaplan; Ari Waisman; Vijay K Kuchroo; Mohamed Oukka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

4.  Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.

Authors:  S A Bishop; T J Hill
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals.

Authors:  C S Raine; U Traugott; S H Stone
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

Review 6.  Myelin basic protein and multiple sclerosis.

Authors:  J N Whitaker
Journal:  Ital J Neurol Sci       Date:  1983-06

7.  Resistance to the induction of EAE in AO rats: its prevention by the pre-treatment with cyclophosphamide or low dose of irradiation.

Authors:  M Mostarica-Stojković; M Petrović; M L Lukić
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

8.  Attempts to suppress experimental allergic neuritis in the rat by pretreatment with antigen.

Authors:  J V Brosnan; R I Craggs; R H King; P K Thomas
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

9.  Genetic control of resistance to clinical EAE accompanied by histological symptoms.

Authors:  D L Gasser; A Goldner-Sauvé; W F Hickey
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 10.  Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.

Authors:  V K Tuohy
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.